" We have four trials underway now. Lets hope she starts some news flow about how they are progressing."
I agree , in that Bec appears to have many good attributes ( both from a qualification & experience perspective in the field & managerial / sales experience in other ventures )
Communicating progress in a clear manner is important .... and I reckon she is well capable of turning the "spotlight back on" at CHM .
Just on the Market cap aspect of CHM .....by my calcs there are 876 million shares on issue ( I'm not including vested options to people .....so at 2 cents a share , that a market cap of some $17 million ......which given the possible valuations that could be attributed to the IP is absolute chicken shit .
Its likely also that there will be more cap raises ..... ( based on the Extradinary GM agenda )
To put a pessimistic spin on what price the cap raise could be at I'll assume 2 cents
( bear in mind that amount might be overly conservative subject to any interim data that might be released to the market from the trial just announced . - and I - like others hope it is )
However based on a cap raise of 2 cents our market cap will come in at approx 1.6 Bill shares ...and hopefully with a share price of at lease 2 cents - thus a market cap of approx. $32 mill ......which given the possible valuations that could be attributed to the IP is still absolute chicken shit .
Happy to be corrected if my working or assumptions are flawed , and certainly not trying to dampen your optimism Dalts .
Meanwhile ........ a 5 bagger from here is highly possible ( subject to the data & clear communications and relevance of same ...if the results are good ) ......which would put a market cap after the share placement of some $150 mill ..... which given the possible valuations that could be attributed may still prove to be conservative .
As an aside ....assuming she is still holding that would make Jennifer Chows holding worth around $1.8 mill
cheers
VA
- Forums
- ASX - By Stock
- CHM
- Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.3¢

Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial, page-18
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.747M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.858K | 619.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
66 | 58647032 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 107164382 | 32 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
63 | 56847033 | 0.003 |
28 | 24808481 | 0.002 |
18 | 63919000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 99867122 | 31 |
0.005 | 44186931 | 30 |
0.006 | 20755258 | 19 |
0.007 | 3825018 | 5 |
0.008 | 7200898 | 3 |
Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
CHM (ASX) Chart |